Akiko Saito-Moriya

13PUBLICATIONS
104CO-AUTHORS
Medical infection agents (incl. prions)Infant and child healthRespiratory diseasesNeonatologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 29, 2026
Multi-omics analysis of pediatric minimally differentiated acute myeloid leukemia reveals RUNX1-driven stemness and chemoresistance.

|Feb 25, 2026
Combined Tyrosine Kinase Inhibitors and Chemotherapy Based on Minimal Residual Disease in Children With Ph+ Acute Lymphoblastic Leukemia: A Phase 2 Single-Arm Trial, JCCG ALL-Ph13.

Atsushi Sato, Yuichi Kodama, Hirohide Kawasaki

|Jul 16, 2025
Post-Diagnosis Hemorrhagic Events Are Strongly Associated With Poor Survival in Patients With Essential Thrombocythemia.

Yoshinori Hashimoto, Tomoki Ito, Akihiko Gotoh

|Jun 10, 2025
A prospective study evaluating the safety and pharmacokinetics of ponatinib at a fixed dose in six paediatric patients with philadelphia chromosome-positive leukaemia: JCCG PedPona19 study.

Yuichi Kodama, Masanori Nishi, Atsushi Sato

|Dec 11, 2024
Growth retardation and adult height in pediatric patients with chronic-phase chronic myeloid leukemia treated with tyrosine kinase inhibitors.

Haruko Shima, Chikako Tono, Akihiko Tanizawa

|Nov 12, 2024
JCCG ALL-B12: Evaluation of Intensified Therapies With Vincristine/Dexamethasone Pulses and Asparaginase and Augmented High-Dose Methotrexate for Pediatric B-ALL.

Motohiro Kato, Yasuhiro Okamoto, Toshihiko Imamura

Pageof 3

Frequent Collaborators

5 joint publications

Katsuyoshi Koh

5 joint publications

Takao Deguchi

4 joint publications

Nobutaka Kiyokawa

4 joint publications

Daisuke Tomizawa